Home LiteratureArticle Details
PMID: 33761 Published · ppublish English Comparative Study Journal Article

Pneumococci resistant to erythromycin.

Canadian Medical Association journal ·Vol. 119 ·No. 9 ·1978-11-04 ·Pages 1044-6

Dixon JM, Lipinski AE

Abstract

Susceptibility to erythromycin was determined for all pneumococci isolated in one laboratory from clinical specimens between 1969 and 1977. All 4724 isolates examined prior to October 1973 were susceptible to erythromycin. From October 1973 to December 1977, 64 (0.71%) of 8995 pneumococcus isolates were resistant to erythromycin. The resistant strains were isolated from 38 patients living in six widely separated communities in Alberta. The erythromycin-resistant strains were of nine capsular types, including six that often cause bacteremic disease and five for which resistance to erythromycin has not been reported hitherto. Certain strains of type 33 and of type 15 were highly resistant, the minimum inhibitory concentration (MIC) of erythromycin being 2000 microgram/mL; these strains were also highly resistant to lincomycin and clindamycin. Resistance in strains of other types was much lower, the MIC of erythromycin being 0.6 to 20 microgram/mL, and all but one of these strains were susceptible to lincomycin and clindamycin. All the erythromycin-resistant pneumococci were suspectible to penicillin.

MeSH Terms
Adolescent Alberta Child Child, Preschool Clindamycin/therapeutic use Drug Resistance, Microbial Erythromycin/therapeutic use Humans Infant Lincomycin/therapeutic use Pneumococcal Infections/drug therapy,microbiology Sepsis/drug therapy,microbiology Streptococcus pneumoniae/drug effects,isolation & purification
Chemicals
Clindamycin Erythromycin Lincomycin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Dixon J M
Lipinski A E
References (13)
13 references, click to expand
  1. Laboratory diagnosis of Pneumococcus infections.
    Bull World Health Organ. 1960;23:5-13 PMID: 14418893
  2. Prevention of pneumococcal pneumonia by vaccination.
    Trans Assoc Am Physicians. 1976;89:184-94 PMID: 14433
  3. Serotypes of pneumococci in pneumonia, meningitis and other pneumococcal infections.
    Aust N Z J Med. 1977 Jun;7(3):267-70 PMID: 20874
  4. Detection and prevalence of pneumococci with increased resistance to penicillin.
    Can Med Assoc J. 1977 Nov 19;117(10):1159-61 PMID: 23894
  5. Pneumococci relatively insensitive to penicillin in Australia and New Guinea.
    Med J Aust. 1974 Sep 7;2(10):353-6 PMID: 4153882
  6. Increased incidence of tetracycline-resistant pneumococci in Liverpool in 1968.
    Lancet. 1969 May 17;1(7603):998-1000 PMID: 4181183
  7. Importance of carbon dioxide in the isolation of pneumococci.
    J Bacteriol. 1966 Nov;92(5):1281-4 PMID: 4380800
  8. Type 6 pneumococcus resistant to erythromycin and lincomycin.
    N Engl J Med. 1967 Apr 13;276(15):852 PMID: 4381364
  9. An erythromycin-resistant pneumococcus.
    Med J Aust. 1968 Jun 29;1(26):1131 PMID: 4385911
  10. Prevalence of types of Diplococcus pneumoniae and their susceptibility to 30 antibiotics.
    Chemotherapy. 1970;15(5):304-16 PMID: 4395554
  11. Infections with beta-Hemolytic Streptococcus resistant to lincomycin and erythromycin and observations on zonal-pattern resistance to lincomycin.
    J Infect Dis. 1974 Oct;130(4):351-6 PMID: 4613758
  12. Erythromycin-resistant pneumococcal osteomyelitis.
    Am J Med. 1970 Jan;48(1):132-6 PMID: 5415405
  13. Streptococcus pneumoniae resistant to penicillin and chloramphenicol.
    Lancet. 1977 Nov 12;2(8046):995-7 PMID: 72950
Article Info
Journal
Canadian Medical Association journal
Abbr.
Can Med Assoc J
ISSN
0008-4409
Published
1978-11-04
Pages
1044-6
Language
English
Region
Canada
NLM ID
0414110
PMCID
PMC1819040
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]